Sources | Names Used |
---|---|
CTRPv2 | BRD-K04800985 |
PharmacoGx | BRD-K04800985 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LYAR | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | DCAF5 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | ARFGEF3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
mRNA | SF3B6 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
mRNA | PHF14 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | ATP6V0C | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | CACNA1C | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | NT5C2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | MTERF1 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
mRNA | TXN2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |